| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.08 |